Introduction
Over the past decade, unprecedented progress has occurred in the understanding and management of the clinical problem set that we label as acute lung injury (ALI) and its more severe variant, the acute respiratory distress syndrome (ARDS). The scale of improved understanding extends from the microcellular level to the epidemiologic sciences that underpin the study of our field. So extensive has the body of recent data become that adequate treatment would require a thick monograph to detail. Consequently, in this brief and selective overview, I can only attempt to present the core concepts of these advances, interpreted within the limited context of my own perspective.
Certain themes continue to recur: the diversity of ALI/ARDS; the complexity of the pathogenetic and therapeutic environments; the time dependence of scientific observations and therapeutic effects; the potential of fragmentary evidence to give rise to misjudgment and iatrogenicity; and the ravages of definitional uncertainty and imprecise classification on clinical research. Over the span of this decade, we have learned that the entity we call ARDS varies over time, between patients, and even regionally within the lungs of an afflicted subject. In many respects, we are not dealing with one problem but with many. This variation may help to explain why the incidence and natural history of this syndrome have been so difficult to nail down [1] [2] [3] . We have learned that the pathogenesis and pathoanatomy of ARDS vary markedly among patients, helping to explain why the therapies we apply have the potential to damage as well as to heal.
Definitions and epidemiologic issues
Although response and prognosis are acknowledged to differ with cause, etiologic differences have largely been ignored when recruiting into clinical trials. The impact of definitional imprecision on the validity of our clinical science and on the application of therapeutics to the individual patient should not be underestimated. Mechanical ventilation provides a good example.
Although not yet confirmed, it has been cogently argued that the etiology for lung injury helps determine the response to ventilatory therapy [4•]. More importantly, most published trials fail to specify the conditions (eg, positive end-expiratory pressure [PEEP] , ventilation mode, spontaneous vs. controlled conditions) under which gas exchange is measured; the trajectory of illness has often gone unheeded; and the response to initial treatment has not been carefully considered prior to enrollment in clinical trials [5] . Perhaps most disturbing of all, recently published studies [6, 7] indicate that experts often fail to agree on whether a chest radiograph is compatible with the most commonly accepted definition of ARDS proposed by the American European Consensus Conference of 1994 [8•]. The rather loose criteria for ALI and ARDS that were set at that conference serve some purposes better than others; broad definitions facilitate recruitment into clinical trials and potentially broaden the applicability of the result. Unquestionably, however, this inclusive approach has had an adverse impact on the discriminating ability of therapeutic clinical trials. Loose definitional criteria may also help to account for the widely varying incidence figures that have emerged from different epidemiologic surveys. From longitudinal studies conducted in single centers, we have learned that ARDS mortality has decreased substantially over the past decade, with major improvement having occurred in the early 1990s [9] . Consistent data from several sources indicate that despite the improving prognosis, late deaths, protracted disability, and lasting psychosocial difficulties are important consequences of the ARDS experience [10] .
taneously activated, antagonistic pathways are key to the problem. In most instances multiple biologic or biophysical "hits" may be needed to initiate such an imbalance; conversely, the complexity of the pathogenesis may dictate that more than one therapeutic pathway needs to be addressed to evoke a healing response [11] . Even if the responsible pathways and interactions driving inflammation were well worked out, genetic polymorphism would introduce wide variation in expression [12] . Furthermore, layered onto the initiating event of ARDS is the complicating influence of the mechanical forces of ventilatory support that may modify ongoing inflammation, delay healing, or repeatedly reinitiate the inflammatory process.
The interplay of cell-cell interactions has been assigned a potentially important and perhaps pivotal function in the acute lung injury process. Certain cell lines are posited to play critical roles in initiating, signaling, mediating, or quelling inflammation. Although the intricate pathobiology of acute lung injury is still poorly understood-particularly how the whole process is sequenced and orchestrated-impressive data assign key roles to macrophages, neutrophils, endothelial cells, epithelial cells, and fibroblasts [13] [14] [15] [16] [17] [18] . A variety of signaling and effector molecules released from these cells have been incriminated. Certain of these inflammatory products not only destroy the normal architecture of the lung but also disrupt the barrier separating gas and blood [18] . Apoptosis, or programmed cell death of the specific cell types involved with inflammation and repair, may be crucial to the resolution of inflammation. This is important, as recent investigations of this biologic process suggest that apoptosis of neutrophils, fibroblasts, and other cell lines may be amenable to drug intervention [19, 20] 
Extrapulmonary organ function
Inflammatory events in the lung do not leave peripheral organs unaffected. Based on data accumulated both in the laboratory and in the clinical setting, it is plausible that inflammatory mediators or protein fragments are released from the lung into the bloodstream, with the potential to inflict injury elsewhere [31•,32,41,42] . That the injured lung serves as the primary generator of multiorgan dysfunction, however, is by no means a proven hypothesis. Whether the nature and concentrations of such products that enter the bloodstream are sufficient to initiate or cause injury elsewhere remains an exciting area of investigation. Conversely, inflammation in the lung may upregulate anti-inflammatory mechanisms that may exert their influence at remote sites; some data suggest that anti-inflammatory influences may predominate in extrapulmonary organs [30] .
The influence of mechanical forces on the inflammatory process now receives considerable attention. Experimental work strongly indicates that cytoskeletal transduction of mechanical forces upregulates the inflammatory response [16, 43] . Repeated cyclical stretch of the endothelium may lead to loss of its integrity or incite biochemical changes that result in edema formation, leukocyte migration, and other key subcellular events. When cellular strain is moderate, other noxious influences may synergize to produce the "two hits" needed to initiate inflammation [14] . Deformation of the alveolar epithelial cells has been shown to result in altered internal chemistry, cytokine release, and an intense lipid trafficking to the site under stress [16, 43] . When deformation becomes excessive, overt breaks in the plasma membrane may allow macromolecules to breach the epithelial membrane barrier, causing catastrophic impairment or death of the affected cell [16] . Such considerations may hold important clinical implications, as the stresses imposed on the mechanically heterogeneous lung are likely to be severalfold higher than the same pressures applied to a uniformly healthy "open" lung [44] . A purely mechanical stimulus applied to healthy lungs of experimental animals has been shown to result in hemorrhagic pulmonary edema and neutrophil infiltration within hours of its application [45, 46] . Whether this is a result of signaling of subcellular events and release of inflammatory mediators with subsequent breakdown of barrier function or whether the stresses applied by high-pressure mechanical ventilation are sufficient in themselves to disrupt the barrier (with inflammation as an epiphenomenon) is an important area of inquiry at the present time.
In summarizing the wealth of new basic information regarding pathogenesis, it is clear that the clinical problem that we recognize as ALI and ARDS is a complex entity whose manifestations of abnormality are detectable along numerous intersecting pathways. Many factors determine the severity of ALI; these are likely to include genetic predisposition as well as the specific modulating cofactors of the inflammatory microenvironment. Such conditioners may include inspired oxygen concentration, PaCO 2 [21], pH, temperature, vascular pressure [47], coagulation status, pharmacologic environment, and other influences yet to be elucidated.
Clinical strategies Imaging
Extending previous work, experimental studies published within the past decade have shown that excessive mechanical stresses developed during mechanical ventilation can inflict injury on both normal and acutely injured lungs [45] . By implication, such forces may also retard healing. Advances in imaging technology have contributed greatly to our understanding of the mechanical heterogeneity of ARDS and in so doing have helped to reshape our ventilatory approach [48, 49] . One imaging technology, positron emission tomography, has proven a useful investigative tool that can provide information regarding structure, function, and spatial-function relationships [50, 51] . Microscanner units are now available that are suitable for study of small animals. Such advanced methodologies may be needed as we enter the gene reporting and targeting era of scientific inquiry into the inflammatory processes of ARDS. More widely available for clinical use is CT scanning, which has shown the highly regionalized nature of consolidation and atelectasis in the early stage of ARDS [48, 49] . CT scanning has also shown that cysts and pseudocysts may develop later in the ventilation process, presumably as a consequence of uneven stresses or regional variations in tissue strength [52] .
Ventilator-induced lung injury
Repeated application of transalveolar pressures that exceed those corresponding to the inflation capacity of a healthy lung may disrupt the alveolar/epithelial barrier, especially in the absence of sufficient end-expiratory pressure to hold open mechanically unstable lung units. Although transalveolar pressure is highest in nondependent areas, tissue stresses and shearing forces may be greatest in the middle and lower zones of the lung most subject to closure. Closure of small airways and alveolar units occurs at low end-expiratory pressure, and high inspiratory pressure repeatedly subjects these tissues to forces that may be severalfold higher than those experienced in the free wall of alveoli that remain inflated throughout the tidal cycle [44] . From a theoretical standpoint, shear stresses at the junction of open and closed tissue will rise to high levels that may mechanically disrupt epithelial or endothelial membranes or incite inflammation.
Reversal of atelectasis, therefore, may not only improve oxygenation but also reduce damaging tissue stresses. This is the primary rationale for employing a lungprotective, "open" lung approach such as the one successfully tested in a clinical trial by Amato et al. [53•] . In that important work, the open lung approach, which emphasized maintained recruitment and avoidance of high plateau pressures, conferred a 28-day overall survival advantage when compared with a more conventional strategy that sought to minimize the end-expiratory pressure used to achieve an acceptable PaO 2 to FiO 2 ratio. High PEEP is not always required for maximum benefit, however. Indeed, it is likely that unnecessarily high PEEP can exaggerate ventilation/perfusion mismatching and increase stresses within tissues that remain uninflated. Limiting end-inspiratory pressure makes sense whether or not an open lung approach is attempted. A low tidal volume approach was associated with reduced mortality in a large multicenter trial conducted by the National Institutes of Health (NIH)-sponsored ARDS Network, further emphasizing the practical importance of reducing mechanical stresses on the lungs [54•]. While it remains logical to reverse atelectasis whenever possible, high PEEP is not always needed or desirable. This point was emphasized in the as yet unpublished results from another ARDS Network clinical trial testing that question.
How PEEP and tidal volume are best selected remains an important and unresolved clinical management issue. Data from recent clinical trials suggest that peak tidal pressures even lower than 30 cmH 2 O may be associated with increased mortality [54•]; therefore, a safe upper limit for plateau pressure cannot yet be specified. Moreover, because end-inspiratory pause (plateau) pressures are influenced by chest wall stiffness as well as by lung properties, higher pressures are not necessarily associated with injurious transalveolar forces, especially when plateau pressure rises as a result of increasing endexpiratory alveolar pressure.
Pressure-volume relationships and recruitment
The inspiratory pressure-volume curve has been in use for many years as a means by which to identify the appropriate PEEP and tidal volume combination [55] . By this guide, the inflection and deflection zones of the inspiratory pressure-volume curve are used to demarcate a "safe" region within which tidal pressures may operate. Yet, the inspiratory pressure-volume curve blends together information coming from all sectors of the lung, and its undulations are influenced by a variety of factors. These include the relative proportions of lung units that are overstretched and recruited [56•], the presence of airway liquids [57] , and the compliance of the chest wall [58] . All may contribute to the shape of the pressurevolume curve. Rarely can one be confident in distinguishing a single pressure or "point" at which tangential compliance abruptly transitions from low to high or vice versa.
The lowest tidal volume that maintains adequate ventilation is not necessarily the least damaging; recent experimental data demonstrate that high tidal volumes may help to recruit lung units that otherwise would remain closed at the same level of PEEP [59, 60] . Moreover, when a low tidal volume is used, maintaining minute ventilation by increasing frequency may not be innocuous, especially at high vascular pressures and flows [61] . Recruitment of unusually adherent alveoli (which tend to be located in dependent lung zones) may require the application of pressures that exceed those corresponding to total lung capacity [60,62•]. Sustained applications of high alveolar pressure, whether by applying an airway pressure in excess of that which normally achieves total lung capacity or by brief application of a tidal ventilation pattern with a high PEEP and plateau pressure, are known as recruitment maneuvers [63] [64] [65] . Although of unproved safety and not always efficacious, such maneuvers often improve oxygenation. When improved oxygenation is observed to result from such maneuvers, higher end-expiratory pressure is generally required after tidal ventilation is resumed to sustain the benefit of lung unit opening [63, 65] . Recruitment maneuvers may be especially important when very small tidal volumes are in use, as in high-frequency oscillation, a technique with an excellent physiologic rationale that is gaining advocates in the clinical setting as well [66] .
Once the lung is recruited, the problem of selecting the most efficacious and least harmful PEEP/tidal volume combination must still be addressed. It has been recently argued that the decremental compliance value as PEEP is lowered might be helpful in identifying the least PEEP value that maintains patency of unstable lung units, but this attractive theoretical approach requires clinical confirmation [67•]. Limiting plateau pressure while using relatively high levels of PEEP to maintain recruitment has a good theoretical rationale but obligates mild to moderate hypercapnia in many patients. While higher PaCO 2 may be poorly tolerated by patients with raised intracranial pressure and those intolerant of vasodilation, recent work demonstrates that hypercapnia may have a salubrious effects on several forms of lung inflammation, including that induced by adverse ventilation strategies [21, 68] .
Numerous cofactors and environmental conditions influence the susceptibility of the lung to ventilation-related damage. In animal experiments, the nature of the underlying lung injury, the vascular pressures used to perfuse the lung [47, 61] , the temperature at which reventilation occurs [69] , and body position [46, 70] have all been shown to influence the result of a given PEEP/tidal volume combination. Although adequate sedation must be given to assure the comfort of the intubated/mechanically ventilated patient, there is theoretical as well as experimental evidence to suggest that preservation of spontaneous breathing tends to improve oxygen exchange [71, 72] . Improved ventilation of dependent regions may indeed be helpful, provided that forceful expiratory effort and increased oxygen consumption are avoided. Forceful thoracic compression at end expiration reduces functional residual capacity and could theoretically contribute to the process of tidal closure and reopening [73] . Moreover, innate biologic variability of the tidal rhythm (whether naturally driven or imposed artificially by a programmed ventilator) appears to serve a recruitment function when compared with monotonous ventilation with the same tidal volume and average frequency [74] . Periodic achievement of pressures that amplify the forces of interdependence to achieve opening is an attractive but unproven explanatory mechanism. Available data suggest that noninvasive ventilation, when it can be successfully applied to the care of such patients, may hold advantages not only for gas exchange but also for avoidance of complications and ultimate prognosis [75] [76] [77] . Unfortunately, because most seriously affected candidates need high inflation pressures, are comatose, and require lengthy periods of life support, they are not good candidates for this attractive methodology.
If preservation of spontaneous breathing activity is beneficial and if biologic variation is to be encouraged, techniques that amplify inspiratory muscle activity such as proportional assist ventilation [78] or neurally adjusted ventilatory assist (NAVA) [79] hold special promise. The latter technique adjusts ventilator output in accordance with a suitably modified and conditioned electromyographic signal. Unlike proportional assist ventilation, which seeks to monitor inspiratory flow and volume, inferring the required pressure based on knowledge of resistance, compliance, and a simplified equation of motion for the respiratory system, NAVA has a theoretical advantage of not being subject to errors induced by unopposed auto-PEEP or "run-away" breathing. NAVA is still in its earliest phases of development and may or may not prove applicable to patients with ALI in its current form.
Prone positioning
Prone positioning improves secretion drainage from the airways, relieves lung compression by the heart, and redistributes transalveolar forces so as to allow expansion of the dorsal regions [80] . Approximately 70% of patients with ALI respond to prone positioning with clinically significant increments in oxygen exchange [81•]. Experimental data demonstrate that ventilator-induced lung injury is attenuated by prone positioning, primarily by reducing the damage sustained in the supine position by dependent dorsal areas [43, 61] . Proning helps to sustain the opening achieved by a lung recruitment maneuver [82] . Despite these benefits, 7 hours of prone positioning for a 10-day period did not improve survival in the overall patient sample in a recently published Italian multicenter trial [83] . Subset analysis, however, did suggest that proning may benefit the most seriously ill patients, those with improved CO 2 exchange after proning, and those ventilated with the highest tidal volumes. Whether more prolonged proning carried out for a greater proportion of the intubation period would have culminated differently is also an important question. A well-designed and executed Spanish multicenter clinical trial of prone positioning carried out for approximately 20 hours per day (not yet published) showed an encouraging but nonstatistically significant trend toward lower mortality for the proned cohort. Unfortunately, as in the Italian trial, this study was terminated with many fewer patients entered than were targeted by the power analysis.
Pharmacologic clinical trials
Numerous pharmacologic interventions have been tried in ARDS, generally with disappointing results in clinical trials. Using this methodology, inhaled nitric oxide, ketoconazole, procysteine, lisofylline, perflubron, surfactant, and glucocorticoids have all been reported to be ineffective or detrimental to patient outcome [24, 25, [84] [85] [86] . Interpretations regarding the efficacy of such agents for individual patients, however, should be undertaken with caution. As already noted, there is considerable variability among patients labeled as having ALI or ARDS, and a therapeutic agent might fail when used in isolation but succeed when used as part of a multipronged attack. Moreover, timing of the intervention may be crucial; several observational studies of modest size suggest, for example, that the phase of ARDS in which corticosteroids are applied has a profound impact on their action [87, 88] . A study that targets the use of corticosteroids in latephase ARDS (LASARS), now completed, has been conducted by the NIH-sponsored ARDS Network. At the time of this writing, the results have not been released to the critical care community. It has also become clear over the past decade that a significant minority of patients presenting with the syndrome of ARDS may have diseases (eg, acute eosinophilic pneumonia) whose immune basis is amenable to steroids, even at an early phase.
Discouraging experiences with clinical trials of prone positioning and pharmacologic treatment have taught us hard lessons. Among the most important are that precise definitions and careful selection of the study cohort are needed before a randomized clinical trial can be usefully translated to clinical practice [89] . Moreover, the complexity of clinical illness, responsiveness to disease and treatment, and variation of practice environments render randomized clinical trials very difficult to execute and limit the relevance of their population-based conclusions to the bedside management of the individual patient. It could be cogently argued that randomized clinical trials are a potentially dangerous methodology when prematurely undertaken, misapplied, or misinterpreted.
Conclusion
The diverse entity identified clinically as the acute respiratory distress syndrome continues to generate observations at the basic and clinical levels that alter prior understanding of the best approach to management. Discoveries of the past decade have been numerous and influential, but with molecular, physiologic, and clinical investigative methodologies steadily improving, there is little reason to expect that the pace of future insights will slow.
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